New Jersey News

A federal jury in Trenton has found in favor of Merck & Co. Inc. in the first suit to go to trial over claims that its osteoporosis drug Fosamax causes fractured femurs.

A New Jersey jury ordered a Johnson & Johnson subsidiary to pay $3.35 million in the first of 2,100 lawsuits over its vaginal mesh implant, and will now weigh punitive damages that may total as much as $16.75 million.

A St. Clair County lawsuit over a drug intended to prevent and treat osteoporosis has made its way to federal court in New Jersey.

Owners and lessees of Kia Sorento sport-utility vehicles are suing the company over an alleged design defect that causes sudden engine failure.

Johnson & Johnson has agreed to ramp up oversight of subsidiaries and to pay up to $10.5 million in attorney fees and costs to settle a shareholders' fraud and misconduct suit.

A company that buys plaintiffs' rights to expected recoveries in civil suits is suing two law firms for a client that left it holding the bag.

In multidistrict securities litigation over the discontinued arthritis medication Vioxx, a federal judge has ordered Merck & Co, to turn over documents it produced earlier during a government investigation.

A federal judge on Tuesday certified as class actions a pair of suits claiming Merck & Co. and the former Schering-Plough Corporation withheld information about the effectiveness of the anticholesterol drug Vytorin.